Arca
Skip to content

Affinity (Tm) Cage System

Intervertebral fusion device with bone graft, lumbar. PMA P000028, from Medtronic Sofamor Danek USA, Inc. (Memphis, TN). Product code MAX, class 3.

As of Nov 17, 2026, P000028 is an FDA PMA held by Medtronic Sofamor Danek USA, Inc., approved on Jun 13, 2002 after 702 days, with no recalls tied to it in FDA's recall database.

  • Approved: Jun 13, 2002
  • Review time: 702 days
  • Supplements: 7
  • Recalls: 0
  • Cited as a predicate by: 16 devices

What FDA Approved

FDA's approval order statement

Approval for the affinity cage system. This device is indicated for anterior cervical interbody fusion procedures in skeletally mature patients with cervical disc disease at one level from the c2-c3 disc to the c7-t1 disc. Cervical disc disease is defined as intractable radiculopathy and/or myelopathy with herniated disc and/or osteophyte formation on posterior vertebral endplates producing symptomatic nerve root and/or spinal cord compression confirmed by radiographic studies. Affinity implants are to be used with autogenous bone graft and implanted via an open, anterior approach.

Pivotal Study

The main clinical evidence FDA relied on, as its Summary of Safety and Effectiveness describes it
Design
Prospective, multicenter, non-randomized, controlled equivalence trial (IDE G960201) vs. single-level autograft iliac crest fusion
Enrolled
202
Where
US, UK
Primary endpoint
Overall success at 24 months (fusion, NDI pain/disability success, neurological success, no revision/removal/supplemental fixation); safety: adverse event rates
Result
Overall success 68% (95% HPD 60% to 74%) device vs. 61% (48% to 75%) control; device at least statistically equivalent to control

Cited as a Predicate

16 later 510(k) summaries name this device as a predicate; the 12 newest

Supplements

7 supplements to this PMA
Jul 25, 2006S008Labeling Change - Indications/instructions/shelf life/tradenameNormal 180 Day Track No User Fee
Aug 24, 2004S006Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Jun 18, 2004S005Labeling Change - Indications/instructions/shelf life/tradenameSpecial (Immediate Track)
Nov 13, 2003S004Postapproval Study ProtocolNormal 180 Day Track No User Fee
Jul 2, 2003S003Express GMP SupplementNormal 180 Day Track
Dec 3, 2002S002Postapproval Study ProtocolNormal 180 Day Track
Aug 13, 2002S001Change Design/Components/Specifications/MaterialReal-Time Process

Other MAX Clearances

The newest 510(k)s for the same product code; their median review was 142 days; see every MAX device

Record

Type
Original PMA, expedited
Received
Jul 11, 2000
Review panel
Orthopedic
Regulation
21 CFR 888.3080

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.